BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31669178)

  • 21. Differentially amplified chromosome 12 sequences in low- and high-grade osteosarcoma.
    Gisselsson D; Pålsson E; Höglund M; Domanski H; Mertens F; Pandis N; Sciot R; Dal Cin P; Bridge JA; Mandahl N
    Genes Chromosomes Cancer; 2002 Feb; 33(2):133-40. PubMed ID: 11793439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary extraskeletal osteosarcoma: a clinicopathological study of 18 cases focusing on MDM2 amplification status.
    Yamashita K; Kohashi K; Yamada Y; Nishida Y; Urakawa H; Oda Y; Toyokuni S
    Hum Pathol; 2017 May; 63():63-69. PubMed ID: 28235629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling Assay.
    Ross DS; Zehir A; Cheng DT; Benayed R; Nafa K; Hechtman JF; Janjigian YY; Weigelt B; Razavi P; Hyman DM; Baselga J; Berger MF; Ladanyi M; Arcila ME
    J Mol Diagn; 2017 Mar; 19(2):244-254. PubMed ID: 28027945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene amplification of CCNE1, CCND1, and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Ooi A; Oyama T; Nakamura R; Tajiri R; Ikeda H; Fushida S; Dobashi Y
    Hum Pathol; 2017 Mar; 61():58-67. PubMed ID: 27864121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptional Profiling Identifies the Signaling Axes of IGF and Transforming Growth Factor-b as Involved in the Pathogenesis of Osteosarcoma.
    Yang R; Piperdi S; Zhang Y; Zhu Z; Neophytou N; Hoang BH; Mason G; Geller D; Dorfman H; Meyers PA; Healey JH; Phinney DG; Gorlick R
    Clin Orthop Relat Res; 2016 Jan; 474(1):178-89. PubMed ID: 26463566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HER2 amplification and overexpression is not present in pediatric osteosarcoma: a tissue microarray study.
    Somers GR; Ho M; Zielenska M; Squire JA; Thorner PS
    Pediatr Dev Pathol; 2005; 8(5):525-32. PubMed ID: 16211448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent amplification and rearrangement of chromosomal bands 6p12-p21 and 17p11.2 in osteosarcoma.
    Lau CC; Harris CP; Lu XY; Perlaky L; Gogineni S; Chintagumpala M; Hicks J; Johnson ME; Davino NA; Huvos AG; Meyers PA; Healy JH; Gorlick R; Rao PH
    Genes Chromosomes Cancer; 2004 Jan; 39(1):11-21. PubMed ID: 14603437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays.
    Squire JA; Pei J; Marrano P; Beheshti B; Bayani J; Lim G; Moldovan L; Zielenska M
    Genes Chromosomes Cancer; 2003 Nov; 38(3):215-25. PubMed ID: 14506695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular profiling of osteosarcoma in children and adolescents from different age groups using a next-generation sequencing panel.
    Guimarães GM; Tesser-Gamba F; Petrilli AS; Donato-Macedo CRP; Alves MTS; de Lima FT; Garcia-Filho RJ; Oliveira R; Toledo SRC
    Cancer Genet; 2021 Nov; 258-259():85-92. PubMed ID: 34666222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis.
    Christgen M; van Luttikhuizen JL; Raap M; Braubach P; Schmidt L; Jonigk D; Feuerhake F; Lehmann U; Schlegelberger B; Kreipe HH; Steinemann D
    Oncotarget; 2016 Dec; 7(50):82733-82740. PubMed ID: 27716627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.
    Yang J; Annala M; Ji P; Wang G; Zheng H; Codgell D; Du X; Fang Z; Sun B; Nykter M; Chen K; Zhang W
    J Hematol Oncol; 2014 Oct; 7():76. PubMed ID: 25300797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
    Jia F; Zhang Z; Zhang X
    J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
    Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
    Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene fusions PAFAH1B1-USP6 and RUNX2-USP6 in aneurysmal bone cysts identified by next generation sequencing.
    Warren M; Xu D; Li X
    Cancer Genet; 2017 Apr; 212-213():13-18. PubMed ID: 28449806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of chromosomal aberrations associated with disease progression and a novel 3q13.31 deletion involving LSAMP gene in osteosarcoma.
    Yen CC; Chen WM; Chen TH; Chen WY; Chen PC; Chiou HJ; Hung GY; Wu HT; Wei CJ; Shiau CY; Wu YC; Chao TC; Tzeng CH; Chen PM; Lin CH; Chen YJ; Fletcher JA
    Int J Oncol; 2009 Oct; 35(4):775-88. PubMed ID: 19724913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of interactive networks of gene expression associated with osteosarcoma oncogenesis by integrated molecular profiling.
    Sadikovic B; Yoshimoto M; Chilton-MacNeill S; Thorner P; Squire JA; Zielenska M
    Hum Mol Genet; 2009 Jun; 18(11):1962-75. PubMed ID: 19286668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COPS3 amplification and clinical outcome in osteosarcoma.
    Yan T; Wunder JS; Gokgoz N; Gill M; Eskandarian S; Parkes RK; Bull SB; Bell RS; Andrulis IL
    Cancer; 2007 May; 109(9):1870-6. PubMed ID: 17366602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Consistent Amplification of FRS2 and MDM2 in Low-grade Osteosarcoma: A Genetic Study of 22 Cases With Clinicopathologic Analysis.
    He X; Pang Z; Zhang X; Lan T; Chen H; Chen M; Yang H; Huang J; Chen Y; Zhang Z; Jing W; Peng R; Zhang H
    Am J Surg Pathol; 2018 Sep; 42(9):1143-1155. PubMed ID: 30001240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic implication of immunohistochemical Runx2 expression in osteosarcoma.
    Won KY; Park HR; Park YK
    Tumori; 2009; 95(3):311-6. PubMed ID: 19688969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.